NCT02827578

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia : a Randomized, Double Blinded, Parallel Design, Active Controlled, Multi-center, Phase 3 Clinical Trial

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 588 (estimated)
• Sponsor: IlDong Pharmaceutical Co Ltd · Industry
• Sex: Male
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

Efficacy and Safety of Tamsulosin/Solifenacin Combination therapy in Patients with voiding symptoms and moderate to severe storage symptoms due to Benign Prostate Hyperplasia : a randomized, double blinded, parallel design, active controlled, multi-center, phase 3 clinical trial

Conditions

• Benign Prostate Hyperplasia

Interventions

Type	Name	Description
DRUG	Tamsulosin	Tamsulosin
DRUG	Solifenacin	Solifenacin
DRUG	Solifenacin placebo	Solifenacin placebo

Timeline

• Start date: 2016-01-01
• Primary completion: 2017-08-01
• Completion: 2017-12-01
• First posted: 2016-07-11
• Last updated: 2016-07-13

Locations

1 site across 1 country: South Korea